BioXcel Therapeutics Statistics
Total Valuation
BTAI has a market cap or net worth of $31.95 million. The enterprise value is $113.19 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, before market open.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BTAI has 27.07 million shares outstanding. The number of shares has increased by 381.58% in one year.
| Current Share Class | 27.07M |
| Shares Outstanding | 27.07M |
| Shares Change (YoY) | +381.58% |
| Shares Change (QoQ) | +53.96% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 7.94% |
| Float | 24.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 49.76 |
| Forward PS | 22.50 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 176.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.83
| Current Ratio | 0.83 |
| Quick Ratio | 0.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -75.47% |
| Return on Invested Capital (ROIC) | -265.48% |
| Return on Capital Employed (ROCE) | 557.90% |
| Weighted Average Cost of Capital (WACC) | 10.81% |
| Revenue Per Employee | $17,351 |
| Profits Per Employee | -$1.89M |
| Employee Count | 37 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.54% in the last 52 weeks. The beta is 0.30, so BTAI's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -38.54% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 2.26 |
| Relative Strength Index (RSI) | 35.02 |
| Average Volume (20 Days) | 1,082,691 |
Short Selling Information
The latest short interest is 2.80 million, so 10.36% of the outstanding shares have been sold short.
| Short Interest | 2.80M |
| Short Previous Month | 1.88M |
| Short % of Shares Out | 10.36% |
| Short % of Float | 11.37% |
| Short Ratio (days to cover) | 0.95 |
Income Statement
In the last 12 months, BTAI had revenue of $642,000 and -$69.90 million in losses. Loss per share was -$5.73.
| Revenue | 642,000 |
| Gross Profit | 478,000 |
| Operating Income | -50.27M |
| Pretax Income | -69.90M |
| Net Income | -69.90M |
| EBITDA | -49.97M |
| EBIT | -50.27M |
| Loss Per Share | -$5.73 |
Full Income StatementBalance Sheet
The company has $28.42 million in cash and $109.66 million in debt, with a net cash position of -$81.24 million or -$3.00 per share.
| Cash & Cash Equivalents | 28.42M |
| Total Debt | 109.66M |
| Net Cash | -81.24M |
| Net Cash Per Share | -$3.00 |
| Equity (Book Value) | -95.46M |
| Book Value Per Share | -4.28 |
| Working Capital | -9.24M |
Full Balance SheetCash Flow
| Operating Cash Flow | -57.62M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 300,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -57.62M |
| FCF Per Share | -$2.13 |
Full Cash Flow StatementMargins
| Gross Margin | 74.45% |
| Operating Margin | -7,829.75% |
| Pretax Margin | -10,887.38% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BTAI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -381.58% |
| Shareholder Yield | -381.58% |
| Earnings Yield | -218.78% |
| FCF Yield | -180.34% |
Analyst Forecast
The average price target for BTAI is $23.00, which is 1,849.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.00 |
| Price Target Difference | 1,849.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 263.49% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 10, 2025. It was a reverse split with a ratio of 1:16.
| Last Split Date | Feb 10, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
BTAI has an Altman Z-Score of -26.26 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.26 |
| Piotroski F-Score | 3 |
